2ndVote Life Neutral Plus ETF
LYFE
LYFE was delisted on the 3rd of August, 2023.
3 hedge funds and large institutions have $581K invested in 2ndVote Life Neutral Plus ETF in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
414% more capital invested
Capital invested by funds: $113K → $581K (+$468K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$439K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27 |
Top Sellers
LYFE Hedge Fund Activity: Q1 2021 in Review
3 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in 2ndVote Life Neutral Plus ETF (LYFE) for Q1 2021, worth a combined $581K — up 414% from $113K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LYFE positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $439K.
- 3 institutional investors held 2ndVote Life Neutral Plus ETF (LYFE) as of Q1 2021, up from 2 in Q4 2020.
- Funds reported $581K of 2ndVote Life Neutral Plus ETF stock for Q1 2021, up 414% quarter-over-quarter.
- 1 fund opened new 2ndVote Life Neutral Plus ETF positions in Q1 2021 and 0 closed out, a net change of +1 holder.
- The largest 2ndVote Life Neutral Plus ETF buyer in Q1 2021 was Tower Research Capital (TRC), an estimated $439K added.
Based on aggregated 13F filings for Q1 2021.